SciELO - Scientific Electronic Library Online

 
vol.29 suppl.1Incidence of Kawasaki disease before and during the covid-19 pandemic in Peru author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Rev.Colomb.Reumatol. vol.29  supl.1 Bogotá Dec. 2022  Epub Feb 04, 2024

https://doi.org/10.1016/j.rcreu.2021.04.006 

Letter to the Editor

"Keep your body in motion": Physical activity and exercise for idiopathic inflammatory myopathies during the COVID-19 pandemic

«Mantenga su cuerpo en movimiento»: actividad física y ejercicio para miopatías inflamatorias idiopáticas durante la pandemia de COVID-19

Rafael Giovani Missea 

Helene Alexandersonb  c 

Alexandre Moura dos Santosa 

Samuel Katsuyuki Shinjoa  * 

a Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil

b Department ofNeurobiology, Care Science and Society, Division of Physiotherapy, Karolinska Institutet, Stockholm, Sweden

c Physiotherapy Clinic, Karolinska University Hospital, Stockholm, Sweden


Dear Editor:

Novel coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, since first reported in Wuhan (China). Governments have implemented social-distancing policies due to COVID-19's high transmissibility and lethality. However, the negative impacts of these measures have included increased mental illness (e.g., anxiety, depression) and decreased physical activity levels, which can increase morbidity and mortality for cardiovascular diseases.1,2

Idiopathic inflammatory myopathies (IIM) are a rare group of systemic autoimmune diseases characterized by chronic impaired skeletal muscle, self-reported fatigue, and pain perception, and reduced aerobic capacity,3 which lead to notable sustained impairments and disability. In addition, patients with IIM have a high prevalence of cardiovascular disease.4-6 Exercise has proven safe for all patients with IIM and can, given in the right dose also reduce disease activity and damage.7 Therefore, besides the conventional treatment with glucocorticoids and immunosuppressive drugs, exercise should be an important part of the treatment for patients with IIM. We recommend that exercise initially should be ideally supervised by a physical therapist, however, later on be self-manages with regular follow-up and progression of exercise. In this way exercise can reduce the risk of comorbidities and improve health.

In the current COVID-19 pandemic scenario, these patients have been affected by adopted social-distancing measures,8 which hamper possibilities of support from health care providers.

Currently, guidelines recommend 150-300 min a week of physical activity. For patients with chronic, low-active disease recommendations for exercise to improve physical capacity, the doses do not seem to diverge from recommendations for healthy.9 Pedometers can be used as a monitoring strategy for walking activities and possibly to promote major adherence by the patient.10 Aerobic capacity is highly associated to self-reported health in people with IIM and heart-rate monitors could help to set a correct exercise intensity to improve aerobic capacity. Another relevant strategy is reducing sitting time.

Home-based exercise training (combined or isolated aerobic or resistance exercise) has been recommended. Technological advances can be useful for providing better interaction between therapists and patients to control exercise intensity, volume, and frequency and to assess the patients' progress. The literature evidences motivate results, such as improved muscle strength function, and aerobic capacity.

In conclusion, maintaining regular physical activity and exercise is eminently important to counteract decreased muscle strength, function, and general physical function and consequently to mitigate cardiovascular risk factors. Beyond this, the interactions between therapists and patients must be valued to promote strong adherence to exercise-training programs.

Such interactions could be a transdisciplinary burden shared with physicians and other health professions such as psychologists and physical therapists, to promote a better approach to behavior changes due to the COVID-19 pandemic.

REFERENCES

1. Pinto AJ, Roschel H, De Sá Pinto AL, Lima FR, Pereira RMR, Silva CA, et al. Physical inactivity and sedentary behavior: overlooked risk factors in autoimmune rheumatic diseases? Autoimmun Rev. 2017;16:667-74, http://dx.doi.org/10.1016/j.autrev.2017.05.001. [ Links ]

2. Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psych. 2020;66:317-20, http://dx.doi.org/10.1177/0020764020915212. [ Links ]

3. Alemo Munters L, Dastmalchi M, Andgren V, Katz A, Esbjörnsson M, Loell I, et al. Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis. A multicenter randomized controlled trial with a 1-year open extension follow-up. Arthritis Care Res (Hoboken). 2013;65:1959-68, http://dx.doi.org/10.1002/acr.22068. [ Links ]

4. De Moraes MT, De Souza FH, De Barros TB, Shinjo SK. Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. Arthritis Care Res (Hoboken). 2013;65:793-9, http://dx.doi.org/10.1002/acr.21879. [ Links ]

5. Silva MG, Borba EF, Mello SB, Shinjo SK. Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients. Clinics (Sao Paulo). 2016;71:709-14, http://dx.doi.org/10.6061/clinics/2016(12)06. [ Links ]

6. Araujo PAO, Silva MG, Borba EF, Shinjo SK. High prevalence of metabolic syndrome in antisynthetase syndrome. Clin Exp Rheumatol. 2018;36:241-7. [ Links ]

7. Alexanderson H. Physical exercise as a treatment for adult and juvenile myositis. J Intern Med. 2016;280:75-96, http://dx.doi.org/10.1111/joim.12481. [ Links ]

8. Booth FW, Roberts CK, Thyfault JP, Ruegsegger GN, Toedebusch RG. Role of inactivity in chronic diseases: evolutionary insight and pathophysiological mechanisms.Physiol Rev. 2017;97:1351-402, http://dx.doi.org/10.1152/physrev.00019.2016. [ Links ]

9. Garber CE, Blissmer B, Dechenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardioresporatory, musculoskeletal and neuromotot fitness in apperently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43:1334-59, http://dx.doi.org/10.1249/MSS.0b013e318213fefb. [ Links ]

10. Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA.2007;298:2296-304, http://dx.doi.org/10.1001/jama.298.19.2296. [ Links ]

Funding This work was funded by: Fundacão de Amparo à Pesquisa do Estado de São Paulo (FAPESP) #2019/12155-5 to RGM, #2018/08735-3 to AMS, and #2019/11776-6 to SKS; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 303379/2018-9 to SKS; Faculdade de Medicina da USP to SKS.

* Corresponding author. E-mail address: samuel.shinjo@usp.br (S.K. Shinjo). 0121-8123/

Conflict of interest

All authors declare no conflict of interest

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License